Drugs targeting the renin-angiotensin-aldosterone system.
about
Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysisAngiotensin-I-converting enzyme and its relativesMMP-12 deficiency attenuates angiotensin II-induced vascular injury, M2 macrophage accumulation, and skin and heart fibrosisStructural Insights into Central Hypertension Regulation by Human Aminopeptidase ADiscovery of VTP-27999, an Alkyl Amine Renin Inhibitor with Potential for Clinical UtilityStructure-Based Design of Substituted Piperidines as a New Class of Highly Efficacious Oral Direct Renin InhibitorsFunctional single-cell hybridoma screening using droplet-based microfluidics.Angiotensin-converting enzyme I/D polymorphism and preeclampsia risk: evidence of small-study biasVasorelaxing and antihypertensive activities of synthesized peptides derived from computer-aided simulation of pepsin hydrolysis of yam dioscorin.Treating hypertension while protecting the vulnerable islet in the cardiometabolic syndromeA pharmacologic inhibitor of the protease Taspase1 effectively inhibits breast and brain tumor growthACE for all - a molecular perspectiveAce revisited: a new target for structure-based drug design.Renin-angiotensin system in the kidney: What is new?Use of Angiotensin receptor blockers in cardiovascular protection: current evidence and future directions.Functional enhancement of AT1R potency in the presence of the TPαR is revealed by a comprehensive 7TM receptor co-expression screen.IGF-1 and insulin exert opposite actions on ClC-K2 activity in the cortical collecting ductsAliskiren and amlodipine in the management of essential hypertension: meta-analysis of randomized controlled trials.Increased methylglyoxal formation with upregulation of renin angiotensin system in fructose fed Sprague Dawley rats.Genetic polymorphism of angiotensin converting enzyme and risk of coronary restenosis after percutaneous transluminal coronary angioplasties: evidence from 33 cohort studiesMolecular targets of antihypertensive peptides: understanding the mechanisms of action based on the pathophysiology of hypertensionLoss of angiotensin-converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosisExtracellular proteases as targets for drug developmentInhibitor and substrate binding by angiotensin-converting enzyme: quantum mechanical/molecular mechanical molecular dynamics studies.ACE2-Ang (1-7) axis is induced in pressure overloaded rat model.Losartan increases bone mass and accelerates chondrocyte hypertrophy in developing skeleton.Structure of the Angiotensin receptor revealed by serial femtosecond crystallography.Angiotensin II increases activity of the epithelial Na+ channel (ENaC) in distal nephron additively to aldosterone.Direct Renin Inhibition with Aliskiren Improves Ischemia-Induced Neovasculogenesis in Diabetic Animals via the SDF-1 Related Mechanism.Protease-activated drug development.Structure of testis ACE glycosylation mutants and evidence for conserved domain movement.Gene Silencing and Haploinsufficiency of Csk Increase Blood PressureProgramming blood pressure in adult SHR by shifting perinatal balance of NO and reactive oxygen species toward NO: the inverted Barker phenomenon.Pharmacokinetics and pharmacokinetic/pharmacodynamic relationships for angiotensin-converting enzyme inhibitors.Structural basis of Ac-SDKP hydrolysis by Angiotensin-I converting enzyme.Angiotensin II accelerates mammary gland development independently of high blood pressure in pregnancy-associated hypertensive mice.Angiotensin-(1-7) and its receptor as a potential targets for new cardiovascular drugs.Angiotensin II stimulation alters vasomotor response to adenosine in mouse mesenteric artery: role for A1 and A2B adenosine receptorsInternational Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].Structural basis for selectivity and diversity in angiotensin II receptors
P2860
Q24646726-D14F83A9-A11A-44F3-91E0-1133093B3789Q24796698-A0DE5AF1-324A-4331-9F16-DECDDED31E43Q27339129-C6E59323-A582-448B-A480-3EBDF6167B18Q27679202-08BC1888-5B04-42A0-9E1C-B853D21CC0E7Q27684098-55E50F21-5A4F-4593-B386-EF4E2DBDBD72Q27684776-E41FECFF-1C1C-46E6-8A0E-7EA45BAFBABEQ30143751-2F52537B-6E54-4BB6-92C1-98935B0478C4Q33267837-F14DB637-BC9D-489E-B31F-041C807A71BEQ33690508-EB2CBB17-950C-41C2-BD82-328B3DF38BEFQ33840829-F38441BF-5F64-4D39-9D35-788682FDBA2FQ34100090-CBDF267F-4759-4B95-B7E2-C758727C0C8DQ34195870-4CDF3293-1FDF-4396-AD78-4CA40EE098D8Q34282839-F1F0D2FB-AA28-4572-A3C1-CAA1B88D9180Q34367671-CB4160B9-35E6-4DF2-A2FF-4D9530D36528Q34614447-02DBE021-0356-4DAD-938E-371F8E689EE9Q34630128-FC6ED5EB-314C-4860-976B-002E2D044FB3Q34801093-13A539C8-8DB7-45FD-ABEA-7D3C84212CE3Q34905891-2733C372-D1A3-4700-8495-149ECB1939FBQ34989872-0A9AD08B-64AD-41E1-A5DC-A51975CF2D85Q35009992-CE5EA122-28FD-45D2-862B-34D71D2B09FCQ35016422-519A47F5-D2C7-48F2-B975-024EA418402FQ35088385-BBFF5CE3-A5B3-4FD0-A58B-E31D0B60FF77Q35116202-BFE2F9D8-2E1E-489D-A86A-6F7F51F79A34Q35167293-BAA9F6C0-CBF8-4311-879A-8612C69BCC8CQ35407065-0DAF14B9-F1F9-4958-ACBB-1AFE33CCAC0EQ35588952-8AC355C0-17FA-4C7A-93F1-07A6B6225CDEQ35592165-EA91ED3B-7805-435C-8186-5DEF995CB71AQ35643832-5DABBFE9-106F-4677-8F1E-98F7FEDADA07Q35754513-3C81F0C8-92BF-473D-A103-958CF0C83F2EQ35811508-C9F1E746-DE43-46FB-9F1A-516BEDAF8950Q35843917-20856B0D-1527-4E32-A11F-C1BFE5751A90Q35890054-4F4E1C0D-4E4E-41FC-8BF7-62600908DB13Q35952223-D060837F-9E52-4A09-AD75-A748553DB614Q35985444-5AD4E0F9-AAE2-432B-88EF-FE02327FF2C6Q36099917-BA82837D-C1C0-44F4-96FE-CAAA613590C4Q36144567-029255F5-85A3-49A8-B737-FD5A0E62B556Q36210919-98214443-DE8F-4EEB-9C83-F1DE51316DAEQ36211196-BF9F6789-5922-44ED-A5A8-B3A6958B11EAQ36241932-E32C4400-31E3-4806-BF3D-7BB1FA51806DQ36335687-860DFE9C-5E39-401C-8495-E582E8467F2B
P2860
Drugs targeting the renin-angiotensin-aldosterone system.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Drugs targeting the renin-angiotensin-aldosterone system.
@ast
Drugs targeting the renin-angiotensin-aldosterone system.
@en
Drugs targeting the renin-angiotensin-aldosterone system.
@nl
type
label
Drugs targeting the renin-angiotensin-aldosterone system.
@ast
Drugs targeting the renin-angiotensin-aldosterone system.
@en
Drugs targeting the renin-angiotensin-aldosterone system.
@nl
prefLabel
Drugs targeting the renin-angiotensin-aldosterone system.
@ast
Drugs targeting the renin-angiotensin-aldosterone system.
@en
Drugs targeting the renin-angiotensin-aldosterone system.
@nl
P2093
P356
P1476
Drugs targeting the renin-angiotensin-aldosterone system.
@en
P2093
David A Calhoun
Mohammad Amin Zaman
Suzanne Oparil
P2888
P304
P356
10.1038/NRD873
P577
2002-08-01T00:00:00Z